This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Additional information about the trial, which is recruiting patients, can be found at clinicaltrials.gov, the abstract presented at the ASCO-GI meeting at ASCO-GI Abstract, and poster at ASCO-GI ...

Summary of Paxalisib Data in Comparison to Temozolomide (existing standard of care) ASCO Conference The American ... figure of 17.7 months represents a strong signal of clinical efficacy.

This ASCO research statement includes timely consensus-driven recommendations and a call for engagement of all research stakeholders. ASCO held multistakeholder meetings with leaders in oncology ...

Significant improvements in the primary study end point of IDFS constituted a signal for further amending the 2020 ASCO guideline. A literature search was conducted to identify phase III trials on the ...